156 related articles for article (PubMed ID: 34224520)
1. Pediatric Invasive Fungal Risk Score in Cancer and Hematopoietic Stem Cell Transplantation Patients With Febrile Neutropenia.
Alali M; Giurcanu M; Elmuti L; Kumar M
J Pediatr Hematol Oncol; 2022 Mar; 44(2):e334-e342. PubMed ID: 34224520
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
[TBL] [Abstract][Full Text] [Related]
3. Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update.
Lehrnbecher T; Robinson P; Fisher B; Alexander S; Ammann RA; Beauchemin M; Carlesse F; Groll AH; Haeusler GM; Santolaya M; Steinbach WJ; Castagnola E; Davis BL; Dupuis LL; Gaur AH; Tissing WJE; Zaoutis T; Phillips R; Sung L
J Clin Oncol; 2017 Jun; 35(18):2082-2094. PubMed ID: 28459614
[TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics and Predictive Factors of Invasive Fungal Disease in Pediatric Oncology Patients with Febrile Neutropenia in a Country with Limited Resources.
Monsereenusorn C; Sricharoen T; Rujkijyanont P; Suwanpakdee D; Photia A; Lertvivatpong N; Traivaree C
Pediatric Health Med Ther; 2021; 12():335-345. PubMed ID: 34285630
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive assessment of the prolonged febrile neutropenia evaluation in pediatric oncology patients.
Whitehurst DA; Friedman DL; Zhao Z; Sarma A; Snyder E; Dulek DE; Banerjee R; Kitko CL; Esbenshade AJ
Pediatr Blood Cancer; 2024 Mar; 71(3):e30818. PubMed ID: 38110594
[TBL] [Abstract][Full Text] [Related]
6. Impact of neutropenia evaluated in terms of the D-index on invasive fungal disease while on empiric or preemptive antifungal treatment strategy in the early phase after allogeneic hematopoietic stem cell transplantation.
Kimura SI; Nakamura Y; Kawamura M; Takeshita J; Kawamura S; Yoshino N; Misaki Y; Yoshimura K; Matsumi S; Gomyo A; Akahoshi Y; Tamaki M; Kusuda M; Kameda K; Wada H; Sato M; Terasako-Saito K; Tanihara A; Nakasone H; Kako S; Kanda Y
Transpl Infect Dis; 2020 Dec; 22(6):e13409. PubMed ID: 32654234
[TBL] [Abstract][Full Text] [Related]
7. Clinical risk score for predicting invasive fungal disease after allogeneic hematopoietic stem cell transplantation: Analysis of the China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study.
Sun Y; Hu J; Huang H; Chen J; Li J; Ma J; Li J; Liang Y; Wang J; Li Y; Yu K; Hu J; Jin J; Wang C; Wu D; Xiao Y; Huang X
Transpl Infect Dis; 2021 Aug; 23(4):e13611. PubMed ID: 33825274
[TBL] [Abstract][Full Text] [Related]
8. Sequential low-dose CT thorax scans to determine invasive pulmonary fungal infection incidence after allogeneic hematopoietic cell transplantation.
Enger K; Tonnar X; Kotter E; Bertz H
Ann Hematol; 2023 Feb; 102(2):413-420. PubMed ID: 36460795
[TBL] [Abstract][Full Text] [Related]
9. Invasive Fungal Disease Among Pediatric and Adolescent Patients Undergoing Itraconazole Prophylaxis After Hematopoietic Stem Cell Transplantation.
Itsaradisaikul S; Pakakasama S; Boonsathorn S; Techasaensiri C; Rattanasiri S; Apiwattanakul N
Transplant Proc; 2021; 53(6):2021-2028. PubMed ID: 33994183
[TBL] [Abstract][Full Text] [Related]
10. Invasive fungal diseases in patients with acute lymphoid leukemia.
Nicolato A; Nouér SA; Garnica M; Portugal R; Maiolino A; Nucci M
Leuk Lymphoma; 2016 Sep; 57(9):2084-9. PubMed ID: 26949001
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and management burden of invasive fungal infections after autologous hematopoietic stem cell transplantation: 10-year experience at a European Pediatric Cancer Center.
Linke C; Tragiannidis A; Ahlmann M; Fröhlich B; Wältermann M; Burkhardt B; Rossig C; Groll AH
Mycoses; 2019 Oct; 62(10):954-960. PubMed ID: 31332851
[TBL] [Abstract][Full Text] [Related]
12. Association Between Depth of Neutropenia and Clinical Outcomes in Febrile Pediatric Cancer and/or Patients Undergoing Hematopoietic Stem-cell Transplantation.
Alali M; David MZ; Danziger-Isakov LA; Bartlett AH; Petty LA; Schwartz T; Pisano J
Pediatr Infect Dis J; 2020 Jul; 39(7):628-633. PubMed ID: 32176187
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis.
Montesinos P; Rodríguez-Veiga R; Boluda B; Martínez-Cuadrón D; Cano I; Lancharro A; Sanz J; Arilla MJ; López-Chuliá F; Navarro I; Lorenzo I; Salavert M; Pemán J; Calvillo P; Martínez J; Carpio N; Jarque I; Sanz GF; Sanz MA
Bone Marrow Transplant; 2015 Nov; 50(11):1465-72. PubMed ID: 26281032
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: a 6-yr analysis from the cologne cohort for neutropenic patients.
Vehreschild MJ; von Bergwelt-Baildon M; Tran L; Shimabukuro-Vornhagen A; Wisplinghoff H; Bangard C; Cornely OA; Vehreschild JJ
Eur J Haematol; 2014 Nov; 93(5):400-6. PubMed ID: 24798021
[TBL] [Abstract][Full Text] [Related]
15. Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study.
Harrison N; Mitterbauer M; Tobudic S; Kalhs P; Rabitsch W; Greinix H; Burgmann H; Willinger B; Presterl E; Forstner C
BMC Infect Dis; 2015 Dec; 15():584. PubMed ID: 26715563
[TBL] [Abstract][Full Text] [Related]
16. Febrile Neutropenia Syndromes in Children: Risk Factors and Outcomes of Primary, Prolonged, and Recurrent Fever.
Alali M; David MZ; Ham SA; Danziger-Isakov L; Pisano J
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e962-e971. PubMed ID: 34133386
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors for Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review.
Fisher BT; Robinson PD; Lehrnbecher T; Steinbach WJ; Zaoutis TE; Phillips B; Sung L
J Pediatric Infect Dis Soc; 2018 Aug; 7(3):191-198. PubMed ID: 28549148
[TBL] [Abstract][Full Text] [Related]
18. Role of management strategies in reducing mortality from invasive fungal disease in children with cancer or receiving hemopoietic stem cell transplant: a single center 30-year experience.
Castagnola E; Bagnasco F; Amoroso L; Caviglia I; Caruso S; Faraci M; Calvillo M; Moroni C; Bandettini R; Cangemi G; Magnano GM; Buffa P; Moscatelli A; Haupt R
Pediatr Infect Dis J; 2014 Mar; 33(3):233-7. PubMed ID: 24136371
[TBL] [Abstract][Full Text] [Related]
19. Combination antifungal treatment for invasive fungal disease after hematopoietic stem cell transplantation in children with hematological disorders.
Qiu KY; Liao XY; Fang JP; Xu HG; Li Y; Huang K; Zhou DH
Transpl Infect Dis; 2019 Jun; 21(3):e13066. PubMed ID: 30859662
[TBL] [Abstract][Full Text] [Related]
20. Cell-free DNA next-generation sequencing successfully detects infectious pathogens in pediatric oncology and hematopoietic stem cell transplant patients at risk for invasive fungal disease.
Armstrong AE; Rossoff J; Hollemon D; Hong DK; Muller WJ; Chaudhury S
Pediatr Blood Cancer; 2019 Jul; 66(7):e27734. PubMed ID: 30941906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]